By Brad Perriello A federal appeals court deals a blow to Medtronic when it upholds the U.S. Patent & Trademark Office’s decision to validate a patent held by NuVasive. A federal appeals court yesterday dealt Medtronic (NYSE:MDT) a 2nd blow in nearly

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone